1. Home
  2. IBP vs GKOS Comparison

IBP vs GKOS Comparison

Compare IBP & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Installed Building Products Inc.

IBP

Installed Building Products Inc.

HOLD

Current Price

$284.78

Market Cap

8.3B

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$96.78

Market Cap

6.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IBP
GKOS
Founded
1977
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.3B
6.9B
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
IBP
GKOS
Price
$284.78
$96.78
Analyst Decision
Hold
Strong Buy
Analyst Count
8
14
Target Price
$276.00
$133.07
AVG Volume (30 Days)
320.2K
678.3K
Earning Date
05-29-2026
05-14-2026
Dividend Yield
1.24%
N/A
EPS Growth
6.70
N/A
EPS
9.71
N/A
Revenue
$2,970,800,000.00
$507,442,000.00
Revenue This Year
$2.46
$23.39
Revenue Next Year
$4.53
$27.46
P/E Ratio
$27.98
N/A
Revenue Growth
1.00
32.33
52 Week Low
$150.83
$73.16
52 Week High
$349.00
$130.23

Technical Indicators

Market Signals
Indicator
IBP
GKOS
Relative Strength Index (RSI) 38.57 28.21
Support Level $254.83 $93.96
Resistance Level $293.53 $97.00
Average True Range (ATR) 14.57 3.77
MACD -6.19 -2.37
Stochastic Oscillator 19.86 1.28

Price Performance

Historical Comparison
IBP
GKOS

About IBP Installed Building Products Inc.

Installed Building Products Inc is an insulation installer serving the residential new construction market and are also a diversified installer of complementary building products, including waterproofing, fire-stopping and fireproofing, garage doors, rain gutters, window blinds, shower doors, closet shelving, mirrors and other products throughout the United States. The company installs fiberglass insulation, spray foam insulation, and cellulose insulation. The company has three operating segments consisting of Installation, Manufacturing and Distribution operations. Majority of revenue is derived from Installation segment.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: